{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:07:29Z","timestamp":1788955649158,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"crossref","award":["DST\/INSPIRE Fellowship\/2023\/IF230052"],"award-info":[{"award-number":["DST\/INSPIRE Fellowship\/2023\/IF230052"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"crossref","award":["5\/4-5\/Adhoc\/217\/Neuro\/2020\/NCD-1"],"award-info":[{"award-number":["5\/4-5\/Adhoc\/217\/Neuro\/2020\/NCD-1"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12739-1","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:30:01Z","timestamp":1788953401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington\u2019s disease"],"prefix":"10.1007","volume":"53","author":[{"given":"Sushmita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajubhai","family":"Dabhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vrunda","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Purushottam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reeteka","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biju","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3572-1441","authenticated-orcid":false,"given":"Ravi","family":"Vijayvargia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"12739_CR1","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/hmg\/2.12.2069","volume":"2","author":"AT Hoogeveen","year":"1993","unstructured":"Hoogeveen AT, Willemsen R, Meyer N et al (1993) Characterization and localization of the huntington disease gene product. Hum Mol Genet 2:2069\u20132073. https:\/\/doi.org\/10.1093\/hmg\/2.12.2069","journal-title":"Hum Mol Genet"},{"key":"12739_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF et al (2015) Huntington disease. Nat Rev Dis Primers 1:1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2015.5","journal-title":"Nat Rev Dis Primers"},{"key":"12739_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate M, Finkbeiner S (2012) Protein aggregates in Huntington\u2019s disease. Exp Neurol 238:1\u201311. https:\/\/doi.org\/10.1016\/j.expneurol.2011.12.013","journal-title":"Exp Neurol"},{"key":"12739_CR4","doi-asserted-by":"crossref","unstructured":"Ghosh R, Tabrizi SJ (2018) Huntington disease. In: Handbook of Clinical Neurology. pp 255\u2013278","DOI":"10.1016\/B978-0-444-63233-3.00017-8"},{"key":"12739_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10863-010-9286-7","volume":"42","author":"YN Jin","year":"2010","unstructured":"Jin YN, Johnson GVW (2010) The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. J Bioenerg Biomembr 42:199\u2013205. https:\/\/doi.org\/10.1007\/s10863-010-9286-7","journal-title":"J Bioenerg Biomembr"},{"key":"12739_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/156652411794474419","volume":"11","author":"R Vidal","year":"2011","unstructured":"Vidal R, Caballero B, Couve A, Hetz C (2011) Converging Pathways in the Occurrence of Endoplasmic Reticulum (ER) Stress in Huntingtons Disease. Curr Mol Med 11:1\u201312. https:\/\/doi.org\/10.2174\/156652411794474419","journal-title":"Curr Mol Med"},{"key":"12739_CR7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DDO Martin","year":"2015","unstructured":"Martin DDO, Ladha S, Ehrnhoefer DE, Hayden MR (2015) Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci 38:26\u201335. https:\/\/doi.org\/10.1016\/j.tins.2014.09.003","journal-title":"Trends Neurosci"},{"key":"12739_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.tcb.2019.05.004","volume":"29","author":"G van Mierlo","year":"2019","unstructured":"van Mierlo G, Veenstra GJC, Vermeulen M, Marks H (2019) The Complexity of PRC2 Subcomplexes. Trends Cell Biol 29:660\u2013671. https:\/\/doi.org\/10.1016\/j.tcb.2019.05.004","journal-title":"Trends Cell Biol"},{"key":"12739_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/hmg\/ddp524","volume":"19","author":"IS Seong","year":"2009","unstructured":"Seong IS, Woda JM, Song JJ et al (2009) Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet 19:573\u2013583. https:\/\/doi.org\/10.1093\/hmg\/ddp524","journal-title":"Hum Mol Genet"},{"key":"12739_CR10","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877. https:\/\/doi.org\/10.1084\/jem.20080178","journal-title":"J Exp Med"},{"key":"12739_CR11","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Tr\u00e4ger U, Wild EJ et al (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J Clin Invest 122:3731\u20133736. https:\/\/doi.org\/10.1172\/JCI64565","journal-title":"J Clin Invest"},{"key":"12739_CR12","doi-asserted-by":"publisher","first-page":"e200340","DOI":"10.1212\/CPJ.0000000000200340","volume":"14","author":"GF Guzauskas","year":"2024","unstructured":"Guzauskas GF, Tabrizi SJ, Long JD et al (2024) Long-term health outcomes of Huntington disease and the impact of future disease-modifying treatments: a decision-modeling analysis. Neurol Clin Pract 14:e200340. https:\/\/doi.org\/10.1212\/CPJ.0000000000200340","journal-title":"Neurol Clin Pract"},{"key":"12739_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40259-022-00519-9","volume":"36","author":"ME Rook","year":"2022","unstructured":"Rook ME, Southwell AL (2022) Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic. BioDrugs 36:105\u2013119. https:\/\/doi.org\/10.1007\/s40259-022-00519-9","journal-title":"BioDrugs"},{"key":"12739_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/18796397251399751","volume":"15","author":"M Farag","year":"2026","unstructured":"Farag M, Tabrizi SJ, Wild EJ (2026) Huntington\u2019s disease clinical trials update: October 2025. J Huntingtons Dis 15:156\u2013166. https:\/\/doi.org\/10.1177\/18796397251399751","journal-title":"J Huntingtons Dis"},{"key":"12739_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells14010042","volume":"14","author":"S Shah","year":"2025","unstructured":"Shah S, Mansour HM, Lucke-Wold B (2025) Advances in Stem Cell Therapy for Huntington\u2019s Disease: A Comprehensive Literature Review. Cells 14:1\u201318. https:\/\/doi.org\/10.3390\/cells14010042","journal-title":"Cells"},{"key":"12739_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/d41573-021-00088-6","volume":"20","author":"K Kingwell","year":"2021","unstructured":"Kingwell K (2021) Double setback for ASO trials in Huntington disease. Nat Rev Drug Discov 20:412\u2013413. https:\/\/doi.org\/10.1038\/d41573-021-00088-6","journal-title":"Nat Rev Drug Discov"},{"key":"12739_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biocel.2008.06.010","volume":"41","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Harikumar KB (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biology 41:40\u201359. https:\/\/doi.org\/10.1016\/j.biocel.2008.06.010","journal-title":"Int J Biochem Cell Biology"},{"key":"12739_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/foods6100092","volume":"6","author":"SJ Hewlings","year":"2017","unstructured":"Hewlings SJ, Kalman DS (2017) Curcumin: A review of its effects on human health. Foods 6:92. https:\/\/doi.org\/10.3390\/foods6100092","journal-title":"Foods"},{"key":"12739_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Patchva S, Aggarwal BB (2013) Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS J 15:195\u2013218. https:\/\/doi.org\/10.1208\/s12248-012-9432-8","journal-title":"AAPS J"},{"key":"12739_CR20","doi-asserted-by":"publisher","first-page":"100771","DOI":"10.1016\/j.hermed.2023.100771","volume":"42","author":"RMF B\u00e1ssoli","year":"2023","unstructured":"B\u00e1ssoli RMF, Audi D, Ramalho BJ et al (2023) The Effects of Curcumin on Neurodegenerative Diseases: a Systematic Review. J Herb Med 42:100771. https:\/\/doi.org\/10.1016\/j.hermed.2023.100771","journal-title":"J Herb Med"},{"key":"12739_CR21","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/foods13111774","volume":"13","author":"G Genchi","year":"2024","unstructured":"Genchi G, Lauria G, Catalano A et al (2024) Neuroprotective Effects of Curcumin in Neurodegenerative Diseases. Foods 13:1774. https:\/\/doi.org\/10.3390\/foods13111774","journal-title":"Foods"},{"key":"12739_CR22","doi-asserted-by":"publisher","first-page":"1625821","DOI":"10.3389\/fphar.2025.1625821","volume":"16","author":"G Wang","year":"2025","unstructured":"Wang G, Zhou X, Pang X et al (2025) Pharmacological effects, molecular mechanisms and strategies to improve bioavailability of curcumin in the treatment of neurodegenerative diseases. Front Pharmacol 16:1625821. https:\/\/doi.org\/10.3389\/fphar.2025.1625821","journal-title":"Front Pharmacol"},{"key":"12739_CR23","doi-asserted-by":"publisher","first-page":"100968","DOI":"10.1016\/j.imr.2023.100968","volume":"12","author":"P Garodia","year":"2023","unstructured":"Garodia P, Hegde M, Kunnumakkara AB, Aggarwal BB (2023) Curcumin, inflammation, and neurological disorders: How are they linked? Integr Med Res 12:100968. https:\/\/doi.org\/10.1016\/j.imr.2023.100968","journal-title":"Integr Med Res"},{"key":"12739_CR24","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.56499\/jppres_14.1.2274","volume":"14","author":"R Estremor-Rodr\u00edguez","year":"2026","unstructured":"Estremor-Rodr\u00edguez R, Redondo-Barrera A, Gil-Cure S et al (2026) Use of curcumin as a potential therapeutic agent in Alzheimer\u2019s disease: A systematic review. J Pharm Pharmacogn Res 14:2274\u20132274. https:\/\/doi.org\/10.56499\/jppres_14.1.2274","journal-title":"J Pharm Pharmacogn Res"},{"key":"12739_CR25","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/ptr.8200","volume":"38","author":"E Azzini","year":"2024","unstructured":"Azzini E, Pe\u00f1a-Corona SI, Hern\u00e1ndez\u2010Parra H et al (2024) Neuroprotective and anti\u2010inflammatory effects of curcumin in Alzheimer\u2019s disease: Targeting neuroinflammation strategies. Phytother Res 38:3169\u20133189. https:\/\/doi.org\/10.1002\/ptr.8200","journal-title":"Phytother Res"},{"key":"12739_CR26","doi-asserted-by":"publisher","first-page":"e1243","DOI":"10.1093\/nutrit\/nuae079","volume":"83","author":"BY Turer","year":"2025","unstructured":"Turer BY, Sanlier N (2025) Relationship of Curcumin with Aging and Alzheimer and Parkinson Disease, the Most Prevalent Age-Related Neurodegenerative Diseases: A Narrative Review. Nutr Rev 83:e1243\u2013e1258. https:\/\/doi.org\/10.1093\/nutrit\/nuae079","journal-title":"Nutr Rev"},{"key":"12739_CR27","doi-asserted-by":"publisher","first-page":"1593191","DOI":"10.3389\/fphar.2025.1593191","volume":"16","author":"Y-H Chang","year":"2025","unstructured":"Chang Y-H (2025) Curcumin as a potential therapeutic agent for Parkinson\u2019s disease: a systematic review. Front Pharmacol 16:1593191. https:\/\/doi.org\/10.3389\/fphar.2025.1593191","journal-title":"Front Pharmacol"},{"key":"12739_CR28","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/biomedicines10081895","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A, Jurcau MC (2022) Therapeutic Strategies in Huntington\u2019s Disease: From Genetic Defect to Gene Therapy. Biomedicines 10:1895. https:\/\/doi.org\/10.3390\/biomedicines10081895","journal-title":"Biomedicines"},{"key":"12739_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/hmg\/ddaf052","volume":"34","author":"R Dabhi","year":"2025","unstructured":"Dabhi R, Mehta R, Kakadiya D, Vijayvargia R (2025) Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington\u2019s disease. Hum Mol Genet 34:1097\u20131107. https:\/\/doi.org\/10.1093\/hmg\/ddaf052","journal-title":"Hum Mol Genet"},{"key":"12739_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.56042\/ijbb.v60i9.4047","volume":"60","author":"R Dabhi","year":"2023","unstructured":"Dabhi R, Mehta R, Paneri J et al (2023) Determination of neuroprotective effects of medium chain fatty acids and their derivatives on mutant huntingtin aggregates, oxidative stress and ATP levels in HD150Q cell line model of Huntington\u2019s disease. Indian J Biochem Biophys 60:741\u2013749. https:\/\/doi.org\/10.56042\/ijbb.v60i9.4047","journal-title":"Indian J Biochem Biophys"},{"key":"12739_CR31","doi-asserted-by":"publisher","unstructured":"Mehta R, Dabhi R, Singh S et al (2026) Decanoic Acid Treatment Alleviates Non-cell Autonomous Transfer of HD Pathology by Secretome of Mutant Huntingtin Expressing Cells. Neurochem Res 51. https:\/\/doi.org\/10.1007\/s11064-026-04691-0","DOI":"10.1007\/s11064-026-04691-0"},{"key":"12739_CR32","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.3390\/nu11081881","volume":"11","author":"L Perrone","year":"2019","unstructured":"Perrone L, Squillaro T, Napolitano F et al (2019) The autophagy signaling pathway: A potential multifunctional therapeutic target of curcumin in neurological and neuromuscular diseases. Nutrients 11:1881. https:\/\/doi.org\/10.3390\/nu11081881","journal-title":"Nutrients"},{"key":"12739_CR33","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.4103\/1673-5374.360289","volume":"18","author":"A Jurcau","year":"2023","unstructured":"Jurcau A, Jurcau C (2023) Mitochondria in Huntington\u2019s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies. Neural Regen Res 18:1472. https:\/\/doi.org\/10.4103\/1673-5374.360289","journal-title":"Neural Regen Res"},{"key":"12739_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s12035-026-05991-w","volume":"63","author":"OK Kuwar","year":"2026","unstructured":"Kuwar OK, Khan S, Maloo A et al (2026) Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson\u2019s and Huntington\u2019s Disease: Molecular Insights and Emerging Interventions. Mol Neurobiol 63:685. https:\/\/doi.org\/10.1007\/s12035-026-05991-w","journal-title":"Mol Neurobiol"},{"key":"12739_CR35","doi-asserted-by":"publisher","first-page":"101035","DOI":"10.1016\/j.bbrep.2021.101035","volume":"27","author":"S Abrahams","year":"2021","unstructured":"Abrahams S, Miller HC, Lombard C et al (2021) Curcumin pre-treatment may protect against mitochondrial damage in LRRK2-mutant Parkinson\u2019s disease and healthy control fibroblasts. Biochem Biophys Rep 27:101035. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101035","journal-title":"Biochem Biophys Rep"},{"key":"12739_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4103\/1673-5374.235029","volume":"13","author":"N Zsindely","year":"2018","unstructured":"Zsindely N, Bodai L (2018) Histone methylation in Huntington\u2019s disease: Are bivalent promoters the critical targets? Neural Regen Res 13:1191\u20131192. https:\/\/doi.org\/10.4103\/1673-5374.235029","journal-title":"Neural Regen Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12739-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12739-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12739-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:30:06Z","timestamp":1788953406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12739-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12739"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12739-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1557"}}